Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ad26.ZEBOV Booster in HIV+ Adults
NCT05064956Phase 2Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Oct 2021
- Primary completion
- Nov 2021
- Modality
- Prophylactic Vaccines, DNA Vaccines
- Countries
- 2
01
Overview
A Phase 2 trial of zabdeno in Ebola virus disease (EVD), sponsored by London School of Hygiene & Tropical Medicine. Started Oct 2021; status: completed.
02
Drugs
zabdeno
03
Conditions
Ebola virus disease (EVD)
Beyond the preview
Go deeper on NCT05064956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05064956.